Search research articles
Contact Us
Filters
Showing results (11-20 of 143) with videos related to
Page
of 15
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 25, 2007
What are the consequences of the fourth case?
Christopher Baum
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 2, 2012
Conditional negative selection of gene-modified hematopoietic stem cells
Christopher Baum
The Journal of Clinical Investigation
|
April 7, 2009
Preventing and exploiting the oncogenic potential of integrating gene vectors
Ute Modlich, Christopher Baum
Nature
|
May 14, 2004
Gene therapy needs both trials and new strategies
David Williams, Christopher Baum
Current Gene Therapy
|
December 6, 2012
Vectorizing mRNA and proteins
Axel Schambach, Christopher Baum
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 30, 2004
Gene therapy for inherited disorders of haematopoietic cells
Christoph Klein, Christopher Baum
Current Opinion in Molecular Therapeutics
|
November 7, 2003
Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives
Christopher Baum, Boris Fehse
Human Gene Therapy
|
March 16, 2011
Promoter competition for gene therapy of SCID-X1
Christopher Baum, Axel Schambach
DNA Repair
|
May 8, 2007
Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
Axel Schambach, Christopher Baum
Human Gene Therapy
|
June 28, 2011
Progress on application and maintenance of nonviral vectors
Hildegard Büning, Christopher Baum
Page
of 15
Search research articles
Search
Showing results (11-20 of 143) with videos related to
Sort By:
Page
of 15
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 25, 2007
What are the consequences of the fourth case?
Christopher Baum
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 2, 2012
Conditional negative selection of gene-modified hematopoietic stem cells
Christopher Baum
The Journal of Clinical Investigation
|
April 7, 2009
Preventing and exploiting the oncogenic potential of integrating gene vectors
Ute Modlich, Christopher Baum
Nature
|
May 14, 2004
Gene therapy needs both trials and new strategies
David Williams, Christopher Baum
Current Gene Therapy
|
December 6, 2012
Vectorizing mRNA and proteins
Axel Schambach, Christopher Baum
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 30, 2004
Gene therapy for inherited disorders of haematopoietic cells
Christoph Klein, Christopher Baum
Current Opinion in Molecular Therapeutics
|
November 7, 2003
Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives
Christopher Baum, Boris Fehse
Human Gene Therapy
|
March 16, 2011
Promoter competition for gene therapy of SCID-X1
Christopher Baum, Axel Schambach
DNA Repair
|
May 8, 2007
Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
Axel Schambach, Christopher Baum
Human Gene Therapy
|
June 28, 2011
Progress on application and maintenance of nonviral vectors
Hildegard Büning, Christopher Baum
Page
of 15